Dr Emma Vardy, a Consultant Geriatrician from Salford, UK, explains the findings of a recent JIMD review looking at the impact of phenylketonuria in adulthood. With those who have benefitted from early treatment now approaching their fifth and sixth decades, PKU cannot just be seen as a disease of childhood and more work is needed to look into the long term impact of the condition.
Phenylketonuria, co‐morbidity, and ageing: A review
Emma R.L.C. Vardy, Anita MacDonald, Suzanne Ford, Denise L. Hofman
https://doi.org/10.1002/jimd.12186
view more